Results

1–4 of 4 results for Hani Salehi-Had

Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy
Hani Salehi-Had, MD, FASRS
Annual Meeting Talks
2023
Aflibercept Versus Vitrectomy With Panretinal Photocoagulation for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Hani Salehi-Had, MD, FASRS
On Demand Cases, Courses, and Papers
2021
Anti-VEGF Injections and Risk of Traction Retinal Detachments in Eyes With Proliferative Diabetic Retinopathy: Pooled Analysis of 5 DRCR.net Trials
Hani Salehi-Had, MD, FASRS
Annual Meeting Talks
Anti-VEGF Injections and Risk of Traction Retinal Detachments in Eyes With Proliferative Diabetic Retinopathy: Pooled Analysis of 5 DRCR.net Trials
Hani Salehi-Had, MD, FASRS
Updates from the Field